Rifat Atun MBBS, MBA, DIC, FRCGP, FFPH, FRCP | |
---|---|
Alma mater | University of London, Imperial College London |
Known for | Health systems theory, health systems reform, innovation and health systems |
Awards | Web of Science, Clarivate, World’s Highly Cited Researcher (2020, 2021, 2022), Honorary Master of Arts, Harvard University (2014) |
Scientific career | |
Fields | Global Health Systems, Healthcare Innovation, Systems Theory |
Institutions | Harvard University, Imperial College, University of London |
Website | Official website |
Rifat Atun is a British physician and academic who, as of January 2024, serves as the Professor of Global Health Systems and Director of the Health System Innovation Lab at Harvard University. [1] [2] [3] He is one of the most important figures in the contemporary study of comparative health systems and healthcare innovation and has made substantial contributions to health systems theory, health systems reform, and innovation in health systems. [4] [5] [6] [7]
Atun served as the Faculty Chair for the Harvard Ministerial Leadership Program from 2015 to 2022. [8] He was a member of the Executive Management Team of the Global Fund from 2008 to 2012, where he held the position of Director of Strategy, Performance, and Evaluation. [9] From 2006 to 2013, Atun was a Professor of International Health Management at Imperial College London and Head of the Health Management Group. [10]
In addition to his academic work, Atun has advised governments on health system reforms, the World Bank, WHO, [11] and leading health and life science companies. He served as a senior advisor to the G20 Presidency from 2019 to 2020 and co-chaired the T20 Health Track and the Task Force on Global Health Security and COVID-19 for the G20 Indonesian Presidency. [12] [13] He is a member of the Longitude Prize Committee [14] and the founding Board Chair of Movement Health Foundation, [15] a Swiss foundation that supports innovations aimed at solving major global health challenges through digital solutions. He is also the Founding President of the Global Surgery Foundation based in Geneva. [16]
This section may contain an excessive number of citations .(July 2023) |
Atun's research focuses on health systems performance, design, and innovation. He has published more than 450 articles in leading journals, including NEJM , Nature Medicine , Lancet , Lancet Oncology , JAMA, and Academy of Management Journal . He has also led and participated in 15 Lancet Commissions. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] In 2020, 2021, and 2022, he was recognized by Web of Science as one of the World's Most Highly Cited Researchers. [32]
Atun studied medicine at the University of London as a Commonwealth Scholar. He obtained an MBA [33] from Imperial College London. He is a Fellow of the Royal College of Physicians, the Faculty of Public Health, and the Royal College of General Practitioners in the UK. [34]
Rifat Atun has been awarded many prestigious awards for his excellence works in healthcare researches in the healthcare fields.
Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.
Healthcare Information For All (HIFA) is a global campaign and community of practice of health professionals, publishers, librarians, technologists, researchers, policymakers, and patient representatives, working to improve the availability and use of reliable healthcare information worldwide. The rationale for HIFA is described in a Lancet paper, commissioned by the World Health Organization. The paper notes that the lack of availability and use of reliable healthcare information in low- and middle-income countries is a major contributor to avoidable death and suffering, and recommends multistakeholder action to accelerate progress.
David M. Serwadda is a Ugandan physician, medical researcher, academic, public health specialist and medical administrator. Currently he is a Professor of Public Health at Makerere University School of Public Health, one of the schools of Makerere University College of Health Sciences, a semi-autonomous constituent college of Makerere University, the oldest university in Uganda. Serwadda is also a founding member of Accordia Global Health Foundation's Academic Alliance.
Sir Andrew Paul Haines, FMedSci is a British epidemiologist and academic. He was the Director of the London School of Hygiene & Tropical Medicine from 2001 to 2010.
REG1 is an anticoagulation system consisting of two drugs: pegnivacogin, a single-stranded 31-nucleotide aptamer that binds and inhibits Factor IXa, and anivamersen, a complementary sequence reversal 15-nucleotide control agent. REG1 mechanism of action It involves inhibition of Factor IXa.
Sir Alimuddin Zumla,, FRCP, FRCPath, FRSB is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2023, for the sixth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.
Planetary Health is a multi- and transdisciplinary research paradigm, a new science for exceptional action, and a global movement. Planetary Health refers to "the health of human civilization and the state of the natural systems on which it depends". In 2015, the Rockefeller Foundation–Lancet Commission on Planetary Health launched the concept which is currently being developed towards a new health science with over 25 areas of expertise.
Shekhar Saxena, MD, FRCPsych, DAB, MRC, Psych, since 1998 has worked at the World Health Organization (WHO) and since 2010 has been the Director of the Department of Mental Health and Substance Abuse (MSD) at World Health Organization's Headquarters Office in Geneva, Switzerland. He is recipient of the 2017 Leon Eisenberg Award. In September 2018 joined the Harvard T.H. Chan School of Public Health as visiting professor of Global Mental Health in the Department of Global Health and Population.
Vasant "Vas" Narasimhan is an Indian-American physician and the chief executive officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He worked in McKinsey & Co and Sandoz before joining Novartis.
Oriol Mitjà i Villar is a Catalan-born Spanish researcher and consultant physician in internal medicine and infectious diseases with expertise in poverty-related tropical diseases. He has conducted research at the Lihir Medical Centre in Papua New Guinea since 2010 on new diagnostic and therapeutic tools to eradicate yaws. He was awarded the Princess of Girona Award in the scientific research category. Currently at the Germans Trias i Pujol Research Institute, Mitjà is conducting research on SARS-CoV-2 coronavirus disease (COVID-19) and strategies to control the infection at a community level.
Anita Raj is an American developmental psychologist and global public health researcher focused on sexual and reproductive health, maternal and child health, and gender inequalities including gender-based violence, discrimination and bias. Until 2023, Raj was the Tata Chancellor Professor of Society and Health and was a professor in the Departments of Medicine and Education Studies at the University of California, San Diego. Raj was also the Founding Director of UCSD's Center on Gender Equity and Health. In 2023, Raj was named the Executive Director of the Newcomb Institute at Tulane University.
The Foundation for a Smoke-Free World is an organization focused on smoking harm reduction founded in 2017. It is funded by Philip Morris International (PMI), which had initial plans for $80 million in annual funding. The current pledge agreement from PMI to the Foundation, modified in September 2020, promises $35 million in funding to the Foundation from 2022 through 2029.
Jocalyn Clark is a Canadian Public Health Scientist and the International Editor of The BMJ, with responsibility for strategy and internationalising the journal's content, contributors and coverage. From 2016 to 2022, Jocalyn was an Executive Editor at The Lancet, where she led the Commentary section, coordinated peer review, and edited and delivered collections of articles and Commissions on topics such as maternal and child health, oral health, migration, end of life care and gender equity. She led the Lancet's project to advance women in science, medicine, and global health, #LancetWomen. She is also an Adjunct Professor of Medicine at the University of Toronto and an Honorary Associate Professor at the Institute for Global Health at UCL.
Adavosertib is an experimental anti-cancer drug candidate. It is a small molecule inhibitor of the tyrosine kinase WEE1 with potential antineoplastic sensitizing activity. It is being developed by AstraZeneca. It is being investigated as a treatment for pancreatic cancer with a phase 1 trial, and ovarian cancer, in combination with another anti-cancer drug, gemcitabine, as a phase 2 trial.
Anita Kaniz Mehdi Zaidi is a Pakistani physician. She is the President of the Gender Equality Division and Director of Vaccine Development, Global Health Surveillance, Diarrhea and Enteric Diseases at the Bill & Melinda Gates Foundation. She has previously served as Professor of Paediatrics and Child Health at the Aga Khan University.
World NTD Day or World NTD Day is an awareness day for addressing neglected tropical diseases (NTDs). It is held on January 30 annually.
The Vaccine Confidence Project (VCP) founded in 2010 by Heidi Larson, was developed in response to hesitancy and misinformation on vaccination programmes such as those that caused a boycott of polio eradication efforts in Northern Nigeria in 2003–04. It is an early warning system to identify and evaluate public confidence in vaccines, with the purpose of tackling the problem early, when it is likely to be manageable.
Elisabete Weiderpass-Vainio is a Brazilian cancer researcher who is Director of the International Agency for Research on Cancer, a part of the World Health Organization. Her research considers the epidemiology and prevention of cancer.
Nina Schwalbe is an American public health researcher who is the founder of Spark Street Advisors, a public health think tank based in New York City. Schwalbe specializes in vaccines. She has previously worked at Gavi, UNICEF and USAID.
Felicia Marie Knaul is a British–Canadian health economist who is director of the University of Miami Institute for Advanced Study of the Americas and a professor at the Leonard M. Miller School of Medicine. She is an economist with the Mexican Health Foundation and president of the non-governmental organization Tómatelo a Pecho, an advocacy organisation that promote women's health in Latin America. Her research and leadership has focused around raising awareness of breast cancer in low and middle income countries.
{{cite web}}
: CS1 maint: numeric names: authors list (link){{cite news}}
: CS1 maint: numeric names: authors list (link){{cite web}}
: CS1 maint: numeric names: authors list (link){{cite web}}
: CS1 maint: numeric names: authors list (link)